Mettler-Toledo International (MTD) vs Natera (NTRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Natera (NTRA) has outperformed Mettler-Toledo International (MTD) over the past year, gaining 134.7% versus a gain of 17.1%. Over five years, NTRA leads with a +257.1% price change compared with +8.2% for MTD. Natera is the larger company by market cap ($55.81 billion vs $30.28 billion), about 1.8 times the size.
Mettler-Toledo International converts more of its revenue into profit, with a net margin of 21.6% versus -9.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MTD | NTRA |
|---|---|---|
| Share price | $1,511.17 | $387.22 |
| Market cap | $30.28B | $55.81B |
| 1-day change | -1.45% | -2.11% |
| YTD return | +9.99% | +72.67% |
| 1-year return | +17.14% | +134.71% |
| 5-year return | +8.16% | +257.10% |
| P/E ratio (TTM) | 34.06 | — |
| Forward P/E | 29.19 | — |
| EPS (TTM) | $44.37 | $-1.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.03B | $2.31B |
| Revenue growth (YoY) | +3.98% | +35.90% |
| Net income (latest FY) | $869.19M | $-208.16M |
| Gross margin | 59.37% | — |
| Operating margin | — | -13.44% |
| Net margin | 21.59% | -9.03% |
| 52-week high | $1,585.72 | $437.41 |
| 52-week low | $1,023.05 | $167.99 |
| Distance from 52-week high | -4.70% | -11.48% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | -2.62% | -2.53% |
| Average volume | 184.08K | 1.44M |
| Shares outstanding | 20.04M | 144.14M |
| Employees | 16,600 | 6,135 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NTRA has outperformed MTD by 117.6 percentage points over the past year.
- Mettler-Toledo International is more profitable, keeping 21.6 cents of every revenue dollar as net income versus -9.0 cents for Natera.
- Natera grew revenue faster in its latest fiscal year (+35.90% vs +3.98%).
- The two companies sit in different sectors: Mettler-Toledo International in Industrials and Natera in Health Care.
About Mettler-Toledo International
MTD stock →Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 16,600 employees
About Natera
NTRA stock →Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test.
Health Care · Medical Specialities · 6,135 employees
MTD vs NTRA FAQ
Which is bigger, Mettler-Toledo International or Natera?
Natera (NTRA) is larger, with a market capitalization of $55.81B compared with $30.28B for Mettler-Toledo International (MTD).
Which stock has performed better over the past year, MTD or NTRA?
NTRA returned +134.71% over the past 12 months, compared with +17.14% for MTD (price return, excluding dividends). Past performance does not predict future results.
Are Mettler-Toledo International and Natera in the same industry?
No. Mettler-Toledo International is in the Industrials sector, while Natera is in Health Care.